The prognostic significance of the CRFR1 methylation status is further supported by the findings showing that decreased ccfDNA CRFR1 methylation levels among CRC patients are correlated with tumor aggressiveness and poor clinical outcomes. This evidence concerns the gene CRHR1 and neoplasm.